Daniel Bradbury
Chief Operating Officer, Amylin Pharmaceuticals.
Companies
- Vivani Medical, Inc.Board member Mar 11, 2024 to now1
- Equillium, Inc.Chair May 29, 2020 to now2
- CASTLE BIOSCIENCES INCBoard member Jul 24, 2019 to now3
- Intercept PharmaceuticalsBoard member Jul 21, 2016 to Nov 13, 20234
- Nuvation Bio Inc.Board member Jun 30, 2020 to Feb 26, 20215
- Equillium, Inc.Board member Oct 11, 2018 to Dec 12, 20196
- Equillium, Inc.Chief executive officer Oct 11, 2018 to Dec 12, 20196
- Geron CorporationBoard member Sep 28, 2012 to Apr 1, 20197
- Corcept TherapeuticsBoard member Oct 12, 2012 to Feb 12, 20198
- IlluminaBoard member Jun 9, 2006 to May 26, 20179
- Amylin PharmaceuticalsChief executive officer Mar 20, 2008 to Feb 24, 201210
- Amylin PharmaceuticalsBoard member Mar 6, 2008 to Feb 24, 201211
- Amylin PharmaceuticalsPresident Oct 6, 2006 to Feb 24, 201212
- Paratek Pharmaceuticals, Inc.Board member May 9, 2006 to Feb 15, 200813
- Amylin PharmaceuticalsChief operating officer Jan 9, 2006 to Mar 27, 200714
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CASTLE BIOSCIENCES INC CSTL35,631 shares15$1.1M at $31.96May 27, 2026
- Vivani Medical, Inc. VANI0 shares16Mar 11, 2024
Intercept Pharmaceuticals ICPT0 shares17Nov 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 22, 2026Exercised options 13,667 shares of CASTLE BIOSCIENCES INC15
- May 21, 2025Exercised options 8,673 shares of CASTLE BIOSCIENCES INC18
- Feb 5, 2025Sold 1,425 shares at $28.17 of CASTLE BIOSCIENCES INC19
- Feb 5, 2025Sold 1,425 shares at $28.17 of CASTLE BIOSCIENCES INC19
- Feb 5, 2025Sold 5,017 shares at $28.17 of CASTLE BIOSCIENCES INC19
- Jan 6, 2025Sold 134 shares at $29.82 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 134 shares at $29.82 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 472 shares at $29.82 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 857 shares at $29.41 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 857 shares at $29.41 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 3,015 shares at $29.41 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 434 shares at $28.39 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 434 shares at $28.39 of CASTLE BIOSCIENCES INC20
- Jan 6, 2025Sold 1,530 shares at $28.39 of CASTLE BIOSCIENCES INC20
- Dec 3, 2024Sold 99 shares at $31.32 of CASTLE BIOSCIENCES INC21
- Dec 3, 2024Sold 99 shares at $31.32 of CASTLE BIOSCIENCES INC21
- Dec 3, 2024Sold 348 shares at $31.32 of CASTLE BIOSCIENCES INC21
- Dec 3, 2024Sold 1,326 shares at $30.95 of CASTLE BIOSCIENCES INC21
- Dec 3, 2024Sold 1,326 shares at $30.95 of CASTLE BIOSCIENCES INC21
- Dec 3, 2024Sold 4,669 shares at $30.95 of CASTLE BIOSCIENCES INC21
- Nov 1, 2024Sold 287 shares at $35.33 of CASTLE BIOSCIENCES INC22
- Nov 1, 2024Sold 287 shares at $35.33 of CASTLE BIOSCIENCES INC22
- Nov 1, 2024Sold 1,009 shares at $35.33 of CASTLE BIOSCIENCES INC22
- Nov 1, 2024Sold 763 shares at $34.92 of CASTLE BIOSCIENCES INC22
- Nov 1, 2024Sold 763 shares at $34.92 of CASTLE BIOSCIENCES INC22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVivani Medical, Inc., Board member
- 2SEC EDGAREquillium, Inc., Chair
- 3SEC EDGARCASTLE BIOSCIENCES INC, Board member
- 4
- 5SEC EDGARNuvation Bio Inc., Board member
- 6SEC EDGAREquillium, Inc., Board member
- 7SEC EDGARGeron Corporation, Board member
- 8SEC EDGARCorcept Therapeutics, Board member
- 9SEC EDGARIllumina, Board member
- 10
- 11SEC EDGARAmylin Pharmaceuticals, Board member
- 12SEC EDGARAmylin Pharmaceuticals, President
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARForm 4 filed May 23, 2025
- 19SEC EDGARForm 4 filed Feb 7, 2025
- 20SEC EDGARForm 4 filed Jan 8, 2025
- 21SEC EDGARForm 4 filed Dec 5, 2024
- 22SEC EDGARForm 4 filed Nov 5, 2024